Page last updated: 2024-09-03

vadimezan and aminolevulinic acid

vadimezan has been researched along with aminolevulinic acid in 2 studies

*Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS. [MeSH]

*Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS. [MeSH]

Compound Research Comparison

Studies
(vadimezan)
Trials
(vadimezan)
Recent Studies (post-2010)
(vadimezan)
Studies
(aminolevulinic acid)
Trials
(aminolevulinic acid)
Recent Studies (post-2010) (aminolevulinic acid)
272161016,4756652,740

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Bellnier, DA; Camacho, SH; Cheney, RT; Mazurchuk, R; Oseroff, AR; Seshadri, M; Spernyak, JA1

Other Studies

2 other study(ies) available for vadimezan and aminolevulinic acid

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-dimethylxanthenone-4-acetic acid: implications for combination therapy.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Jun-01, Volume: 11, Issue:11

    Topics: Aminolevulinic Acid; Animals; Antineoplastic Agents; Capillary Permeability; Chlorophyll; Combined Modality Therapy; Dose-Response Relationship, Drug; Immunohistochemistry; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms, Experimental; Neovascularization, Pathologic; Photochemotherapy; Platelet Endothelial Cell Adhesion Molecule-1; Treatment Outcome; Xanthones

2005